Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic GIST: A Phase I/II, Open-Label, Multicenter Study
The oncologist (Dayton, Ohio), 2023-02, Vol.28 (2), p.187 [Peer Reviewed Journal]COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac242
Full text available